» Articles » PMID: 39367088

Investigation of the Risk Factors Associated with Prediabetes in Normal-weight Qatari Adults: a Cross-sectional Study

Overview
Journal Sci Rep
Specialty Science
Date 2024 Oct 4
PMID 39367088
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes is one of the most prevalent chronic diseases in the world, and more people than ever before have impaired glucose tolereance, or prediabetes. Many patients with impaired glucose tolerance and undiagnosed diabetes do not know that their glucose metabolism system has been in a state of disorder. Every year, about 5-10% of prediabetics develop diabetes. One of the important achieving factors may be the increase in blood lipids. However, it is not clear whether triglyceride is associated with impaired glucose tolerance and prediabetes in the Qatari population. Therefore, we investigated the relationship between the first several clinical variables and prediabetes status in normal and overweight populations. We conducted a cross-sectional study using data from the Qatar Biobank program. The study included 5,996 participants who were adults over the age of 20. We collected information about participants' fasting blood glucose levels with other clinical measurements and used various machine learning models and logistic regression to study the association between the clinical measurements and prediabetes for normal and overobese weight groups. The use of several machine learning models showed that, after adjusting the potential confounding factors such as age and sex, Triglyceride has been demonstrated to be positively correlated with prediabetes, and there was a special population dependence phenomenon. Among them, nonobese people (p < 0.05). The effect value and 95% confidence interval and OR of triglyceride on prediabetes was 2.79 and (e0.78, e1.28), respectively.

References
1.
Mainous 3rd A, Tanner R, Jo A, Anton S . Prevalence of Prediabetes and Abdominal Obesity Among Healthy-Weight Adults: 18-Year Trend. Ann Fam Med. 2016; 14(4):304-10. PMC: 4940459. DOI: 10.1370/afm.1946. View

2.
Nogueira J, Cusi K . Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care. Diabetes Spectr. 2024; 37(1):20-28. PMC: 10877218. DOI: 10.2337/dsi23-0013. View

3.
Stephens C, Easton J, Robles-Cabrera A, Fossion R, De la Cruz L, Martinez-Tapia R . The Impact of Education and Age on Metabolic Disorders. Front Public Health. 2020; 8:180. PMC: 7326131. DOI: 10.3389/fpubh.2020.00180. View

4.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

5.
Wongtrakul W, Charatcharoenwitthaya N, Charatcharoenwitthaya P . Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis. Ann Hepatol. 2024; 29(3):101288. DOI: 10.1016/j.aohep.2024.101288. View